CDKN1A and neoplasm: Our study demonstrated that the tumor suppressor properties of GITR are characterized by inhibition of proliferation and induction of apoptosis as well as induction of downstream targets of p53, such as p21, MDM2, Fas, IGF-BP3 and CD82.